Cambiotics , a pioneering biotech company developing next-generation precision health solutions, has successfully closed a Seed investment round of EUR ~4 million with an international consortium, led by the investor Collaborative Fund , with participation from EIFO (Danish Export and Investment Fund), and True , as co-...

Dr Ritwick Sawarkar, Group Leader at the MRC Toxicology Unit, alongside Dr Kadri Seppa, a Postdoctoral Researcher in the lab, have been awarded €150,000 from the European Research Council (ERC) to develop a novel mRNA therapeutic approach to treat Alzheimer's disease. Dementia affected 55 million people in 2020, and cases...

Professor Kiran Patil, MRC Investigator at the MRC Toxicology Unit has been given the Clarivate Web of Science Highly Cited Award for 2025 . The highly cited program celebrates individuals who have demonstrated a significant influence on their field of research and the wider scientific community. The researchers selected...

The MRC Toxicology Unit is part of a £15.9 million initiative from the Medical Research Council (MRC), Innovate UK and the Wellcome Trust to advance promising ‘human in vitro models’. This sits alongside new UK government strategy to reduce animal testing, speeding up plans to phase out the use of animals in science...

The MRC Toxicology Unit are joining an interdisciplinary team on a major new initiative that aims to redefine human-based research models for greater understanding of disease and the acceleration of new medicines. The joint £15.9 million investment by the UKRI Medical Research Council (MRC), Wellcome and UKRI Innovate UK...

The MRC Toxicology Unit and Department of Biochemistry at the University of Cambridge, AstraZeneca, Cancer Research UK Scotland Institute, and the Mary Lyon Centre at MRC Harwell have been awarded a £3.4 million Medical Research Council Prosperity Partnership grant to fund research into understanding the early safety...

Niall Buckley recently attended this year's Gordon Research Conference (GRC) on the Molecular and Cellular Mechanisms of Toxicity in New Hampshire thanks to a travel grant from the EUROTOX Congress. Niall, a postdoc in the MacFarlane lab and AstraZeneca Hepatic Safety Team, presented his work on how CDK9 inhibitors can...

The UK Proteostasis Network, launched by The Babraham Institute in 2024 with support from the Department of Pharmacology, University of Cambridge and the MRC Toxicology Unit has been awarded a £600,000 Network Grant from the Biotechnology and Biological Sciences Research Council (BBSRC). This grant will support the...

It was announced today that Dr Kiran Patil, Principal Investigator at the MRC Toxicology Unit, has been awarded €150,000 from the European Research Council (ERC) to develop novel live biotherapeutics for boosting cancer therapy. In this ERC funded project, Kiran’s group will use their expertise in microbial co-evolution to...

It was announced today that Dr James Thaventhiran, principal investigator at the MRC Toxicology Unit and clinical immunologist has received the prestigious Lister Fellowship award with £300,000 research funding commencing in October. The Lister Institute of Preventative Medicine is dedicated to supporting scientists...